乳腺MRI BI-RADS 3:患者层面因素对短期随访依从性的影响
回顾性纳入2011年2月1日至2016年6月30日期间乳腺MRI评估为BI-RADS 3的190例女性,106例(57.3%)依从推荐随访,34例(18.4%)延迟随访,45例(24.3%)不依从。检查原因、乳腺癌个人史和家族史与依从性显著相关。作者认为部分患者可能从额外支持和资源中获益以提高总体依从性和及时依从性。
要点
- 乳腺MRI BI-RADS 3推荐6个月随访,本队列仅57.3%及时依从,24.3%不依从。
- 检查原因、乳腺癌个人史和家族史与随访依从性显著相关。
- 作者认为部分患者可能从额外支持和资源中获益以提高依从性。
核心结论
- 190例乳腺MRI BI-RADS 3患者中75.7%进行了随访MRI,但仅57.3%为及时随访;检查原因、乳腺癌个人史和家族史与依从性显著相关。
研究设计与样本
- 回顾性研究,纳入2011年2月1日至2016年6月30日期间乳腺MRI评估为BI-RADS 3的全部患者共190例女性,从电子病历提取人口学资料和乳腺相关病史,随访MRI在3至10个月之间视为依从,采用单因素和多因素分析识别与依从性相关的患者层面因素。
诊断标准与关键数值
- BI-RADS 3评估用于乳腺MRI发现估计乳腺癌概率小于2%时。
- 此类患者通常推荐6个月随访MRI。
- 随访MRI在3至10个月之间就诊视为依从。
- 190例中106例依从(57.3%),34例延迟随访(18.4%),45例不依从(24.3%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: A BI-RADS 3 assessment on breast MRI is given when a finding is estimated to have less than 2% chance of breast cancer. Patients in this category are typically recommended to return for a 6-month follow-up MRI. Compliance with this recommendation is low, and we aim to understand which factors are associated with compliance.
MATERIALS AND METHODS: All patients with an MRI examination given a BI-RADS category 3 between February 1, 2011, and June 30, 2016, were retrospectively reviewed. Patient demographics and breast-related medical history were extracted from the electronic medical record. Patients presenting for follow-up MRI between 3 and 10 months were considered compliant. Univariate and multivariate analysis was performed to identify which patient-level factors were associated with compliance with follow-up MRI.
RESULTS: Overall, 190 women with a BI-RADS 3 assessment on MRI were included in the study. Of these women, 106 were compliant with the recommended follow-up MRI (57.3%), 34 had delayed follow-up (18.4%), and 45 were noncompliant (24.3%). Reason for examination, personal history of breast cancer, and family history of breast cancer were significantly associated with compliance.
CONCLUSIONS: We found that 75.7% of patients had a follow-up MRI after a BI-RADS 3 assessment, but only 57.3% were timely in their follow-up. Our data suggest that there may be subsets of patients who would benefit from additional support and resources to help increase overall compliance and timely compliance.
引用
- Ambinder EB, Myers K, Panigrahi B, et al. Breast MRI BI-RADS 3: Impact of Patient-Level Factors on Compliance With Short-Term Follow-Up. J Am Coll Radiol. 2019. PMID: 31604077. doi:10.1016/j.jacr.2019.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。